Xiamen Amoytop Biotech Co Ltd (688278 SHG) stock market data APIs
¥75.8572
0.4(0.5%)
as of January 22, 2026
Try our APIs with
free plan!
Xiamen Amoytop Biotech Co Ltd Financial Data Overview
Price chart is built with
Anychart
Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally. It offers various drug products, such as pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin; active pharmaceutical ingredients (APIs); and reagents to treat viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is headquartered in Xiamen, China.
Prev. Close
75.8572
Open
76.2608
High
77.6266
Low
74.6985
52 wk Range
67.96-93.52
Market Cap
31 190 M
P/E Ratio
33.0779
Shares Outstanding
408 M
Revenue
3 342 M
EPS
0.6
Dividends (Yield)
0.0079
Beta
-0.113
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Xiamen Amoytop Biotech Co Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Xiamen Amoytop Biotech Co Ltd data using free add-ons & libraries
Get Xiamen Amoytop Biotech Co Ltd Fundamental Data
Xiamen Amoytop Biotech Co Ltd Fundamental data includes:
- Net Revenue: 3 342 M
- EBITDA: 1 102 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-22
- EPS/Forecast: 0.82
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Xiamen Amoytop Biotech Co Ltd News
New
Global's January 2026 Stock Picks For Estimated Value Opportunities
As global markets navigate a complex landscape marked by U.S. labor market weaknesses, geopolitical tensions, and fluctuating economic indicators, investors are keenly exploring opportunities in under...
3 Asian Stocks Estimated To Be Up To 49.5% Below Intrinsic Value
As global markets show signs of resilience, with major indices reaching new highs despite geopolitical tensions, investors are increasingly turning their attention to Asia for opportunities. In this e...
Asian Value Stock Picks For Intrinsic Valuation Estimates January 2026
As we enter 2026, Asian markets are navigating a complex landscape marked by mixed performances in major economies like China and Japan, with slight gains in manufacturing and technology sectors amid ...
Asian Value Stocks Estimated Up To 38.4% Below Intrinsic Value
As global markets navigate a complex landscape of economic indicators and geopolitical tensions, investors are increasingly turning their attention to the Asian market for opportunities. In this envir...
Get Xiamen Amoytop Biotech Co Ltd fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
